|
Post by thekindaguyiyam on Apr 18, 2015 14:07:11 GMT -5
|
|
|
Post by kball on Apr 18, 2015 15:21:52 GMT -5
Fan of John's. Loved him on the daily show and he seems to have found his stride on his new show tackling/mocking longer form stories. A voice that will only grow in importance once Stewart moves on from the top of the heap
|
|
|
Post by tigiron on Apr 18, 2015 15:47:07 GMT -5
openpaymentsdata.cms.gova database where you can search for information on pharmaceutical company's transactions (payments and free lunches, etc...), a good source for physician / doctor / MD industrial pharmaceutical connection.
|
|
|
Post by thekindaguyiyam on Apr 18, 2015 17:54:07 GMT -5
With Respect to the Physicians on this board, I provided John Oliver's thesis as part of an obstacle to slow down Afrezza sales. On the other hand; social media will drive demand and those doctors who are receiving will no longer hold back the tide of Patients demands.
Had to change endo and met the new doc. Scientific fella but told me out flat that he won't prescribe Afrezza until a larger population provides consensus. He wanted me to take metformin; and I told him absolutely Not. So, I most likely will part ways with this physician.
No offense Docs.
|
|
|
Post by mnholdem on Apr 18, 2015 18:09:08 GMT -5
If they study the medical literature Sanofi provides and still tie a "wait and see" approach to Afrezza, endocrinologists will lose many patients, especially after consumer ads begin. By that time, many diabetics will have heard of Afrezza's results via social media.
Perhaps the ultra-conservative endos will deserve to lose patients... They won't get them back either, not once patients dial in their Afrezza doses.
You snooze, you lose.
|
|
|
Post by kball on Apr 18, 2015 20:25:09 GMT -5
My preference would be that I underestimate, not the size of the market, but rather the speed at which Afrezza is adopted by diabetics.
And that I have the wisdom and patience to see which one it is...
Come to think of it...underestimating market size wouldnt be so bad either
|
|